Apogee Therapeutics, Inc. (APGE)

USD 44.69

(-7.07%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022
Total Assets 401.4 Million 152.05 Million
Total Current Assets 398.4 Million 152.05 Million
Cash And Short Term Investments 395.45 Million 151.89 Million
Cash and Cash Equivalents 118.31 Million 151.89 Million
Short Term Investments 277.14 Million -
Net Receivables - -
Inventory - -
Other Current Assets 2.95 Million 57 Thousand
Total Non-Current Assets 2.99 Million -
Net PPE 2.59 Million -
Good Will And Intangible Assets - -
Good Will - -
Intangible Assets - -
Long-Term Investments 300 Thousand -
Tax Assets - -
Other Non Current Assets 101 Thousand -
Other Assets - -
Total Liabilities 21.49 Million 9.98 Million
Total Current Liabilities 20.55 Million 9.98 Million
Account Payables 2.14 Million 418 Thousand
Tax Payables - -
Short Term Debt 1.1 Million -
Deferred Revenue - -
Other Current Liabilities 17.31 Million 9.56 Million
Total Non Current Liabilities 932.99 Thousand -
Long-Term Debt 933 Thousand -
Deferred Revenue Non Current - -
Deferred Tax Liabilities Non Current - -
Other Non Current Liabilities -1.00 -
Other Liabilities 1.00 -
Total Equity 379.91 Million -39.78 Million
Stock Holders Equity 379.91 Million -39.78 Million
Common Stock - 4.39 Million
Retained Earnings -123.77 Million -39.78 Million
Accumulated other comprehensive income 329 Thousand -221.64 Million
Common Stock Equity 379.91 Million -39.78 Million
Capital Lease Obligation 933 Thousand -
Total Investments 277.44 Million -
Total Debt 2.03 Million -
Net Debt -116.28 Million -151.89 Million

Balance Sheet Charts